drugset / Trial / NCT00101790
A Pilot Trial of Intravenous (IV) Pamidronate for Low Back Pain
Phase 1
Unknown
44 enrolled
Icahn School of Medicine at Mount Sinai
National Institute of Neurological Disorders and Stroke (NINDS) · collab
RandomizedSingle-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the test dose of pamidronate for treatment of low back pain in terms of safety, tolerability, and pain relief.
Timeline
- Start
- 2003-09
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pamidronate | Small molecule | 30 mg | Intravenous |
| Comparator | Pamidronate | Small molecule | 60 mg | Intravenous |
| Comparator | Pamidronate | Small molecule | 90 mg | Intravenous |
Indications
No indication recorded.